European Medicines Agency. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: EMA; 2006:5.
Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. Washington, DC: U.S. Department of Health and Human Services; 2009.
Goodman, CS. Healthcare technology assessment: Methods, framework, and role in policy making. Am J Manag Care. 1998;4 Spec No:SP200-14.
Jackowski, D, Guyatt, G. A guide to health measurement. Clin Orthop Relat Res.
Kleijnen, S, Goettsch, W, d'Andon, A, et al.
EUnetHTA JA WP5: Relative Effectiveness Assessment (REA) of pharmaceuticals. Background review. July 2011 (version 5B). Copenhagen: EUnetHTA; 2011.
Fitzpatrick, R, Davey, C, Buxton, MJ, Jones, DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess.
Guyatt, GH, Feeny, DH, Patrick, DL. Measuring health-related quality of life. Ann Intern Med.
Neyt, M. Towards more consistent use of generic quality-of-life instruments. Pharmacoeconomics. 2010;28:345–346.
Stull, DE, Leidy, NK, Parasuraman, B, Chassany, O. Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. Curr Med Res Opin.
Machin, D, Weeden, S. Suggestions for the presentation of quality of life data from clinical trials. Stat Med.
Petrillo, J, Cairns, J.
Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Expert Rev Pharmacoecon Outcomes Res.
Chuang, LH, Kind, P. Converting the SF-12 into the EQ-5D: An empirical comparison of methodologies. Pharmacoeconomics. 2009;27:491–505.
Wild, D, Eremenco, S, Mear, I, et al.
Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Value Health. 2009;12:430–440.
Ware, JE Jr, Keller, SD, Gandek, B, Brazier, JE, Sullivan, M. Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment. Int J Technol Assess Healthcare. 1995;11:525–551.
Gao, F, Ng, GY, Cheung, YB, et al.
The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. J Clin Epidemiol.
Hahn, EA, Bode, RK, Du, H, Cella, D. Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial. Clin Trials. 2006;3:280–290.
Coons, SJ, Gwaltney, CJ, Hays, RD, et al.
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009;12:419–429.
Hacker, ED. Technology and quality of life outcomes. Semin Oncol Nurs.
Hoedemaekers, R, Dekkers, W. Key concepts in health care priority setting. Health Care Anal.
Staquet, M, Berzon, R, Osoba, D, Machin, D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res.
Calvert, MJ, Freemantle, N. Use of health-related quality of life in prescribing research. Part 2: Methodological considerations for the assessment of health-related quality of life in clinical trials. J Clin Pharm Ther.
Billingham, LJ, Abrams, KR, Jones, DR. Methods for the analysis of quality-of-life and survival data in health technology assessment. Health Technol Assess.
Fayers, PM, Machin, D. Quality of life: Assessment, analysis, and interpretation. Chichester, New York: John Wiley; 2000.
Kristensen, F, Sigmund, H. Health technology assessment handbook. Copenhagen: Danish Centre for Health Technology Assessment, National Board of Health; 2007.